138 related articles for article (PubMed ID: 9186278)
1. A new approach to the development of anti-ischemic drugs. Substances that counteract the deleterious effect of lysophosphatidylcholine on the heart.
Hashizume H; Hoque AN; Magishi K; Hara A; Abiko Y
Jpn Heart J; 1997 Jan; 38(1):11-25. PubMed ID: 9186278
[TBL] [Abstract][Full Text] [Related]
2. A new approach to the development of anti-ischemic drugs: protective drugs against cell injury induced by lysophosphatidylcholine.
Hashizume H; Chen M; Ma H; Hara A; Yazawa K; Akahira M; Xiao CY; Abiko Y
Life Sci; 1998; 62(17-18):1695-9. PubMed ID: 9585159
[TBL] [Abstract][Full Text] [Related]
3. A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart.
Hoque AN; Hoque N; Hashizume H; Abiko Y
Jpn J Pharmacol; 1995 Mar; 67(3):233-41. PubMed ID: 7630041
[TBL] [Abstract][Full Text] [Related]
4. [Cardiac cell injury induced by lysophosphatidylcholine].
Hashizume H; Abiko Y
Nihon Yakurigaku Zasshi; 1999 Nov; 114(5):287-93. PubMed ID: 10621942
[TBL] [Abstract][Full Text] [Related]
5. [A new approach to the understanding of the mechanism of ischemia/reperfusion damage in the heart and the effects of anti-ischemic drugs].
Abiko Y; Hashizume H; Hara A
Nihon Yakurigaku Zasshi; 1996 Oct; 108(4):195-202. PubMed ID: 8940701
[TBL] [Abstract][Full Text] [Related]
6. Effects of beta-adrenoceptor antagonists on Ca(2+)-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes.
Chen M; Hashizume H; Abiko Y
Br J Pharmacol; 1996 Jun; 118(4):865-70. PubMed ID: 8799555
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidylcholine accumulation in cardiomyocytes requires thrombin activation of Ca2+-independent PLA2.
McHowat J; Creer MH
Am J Physiol; 1997 Apr; 272(4 Pt 2):H1972-80. PubMed ID: 9139985
[TBL] [Abstract][Full Text] [Related]
8. Extracellulary administered lysophosphatidylcholine causes Ca2+ efflux from freshly isolated adult rat cardiomyocytes.
Itoh K; Yoshizumi M; Kitagawa T; Fukuta Y; Hori T; Houchi H; Tamaki T; Katoh I
Basic Res Cardiol; 1998 Feb; 93(1):23-9. PubMed ID: 9538934
[TBL] [Abstract][Full Text] [Related]
9. Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis.
Corr PB; Yamada KA
Herz; 1995 Jun; 20(3):156-68. PubMed ID: 7543431
[TBL] [Abstract][Full Text] [Related]
10. Effects of endogenous and exogenous lysophosphatidylcholine in isolated perfused rat hearts.
Sargent CA; Vesterqvist O; Ogletree ML; Grover GJ
J Mol Cell Cardiol; 1993 Aug; 25(8):905-13. PubMed ID: 8263961
[TBL] [Abstract][Full Text] [Related]
11. Ethanol delays and reverses lysophosphatidylcholine-induced calcium overload in neonatal rat heart cells.
Gailis L; Lamarche J; Boudriau S; Chahine M; Daleau P
Pflugers Arch; 2001 Oct; 443(1):48-53. PubMed ID: 11692265
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidylcholine-induced arrhythmias and its accumulation in the rat perfused heart.
Man RY
Br J Pharmacol; 1988 Feb; 93(2):412-6. PubMed ID: 3359113
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholine-induced myocardial damage is inhibited by pretreatment with poloxamer 188 in isolated rat heart.
Watanabe M; Okada T
Mol Cell Biochem; 2003 Jun; 248(1-2):209-15. PubMed ID: 12870676
[TBL] [Abstract][Full Text] [Related]
14. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart.
DaTorre SD; Creer MH; Pogwizd SM; Corr PB
J Mol Cell Cardiol; 1991 Feb; 23 Suppl 1():11-22. PubMed ID: 2038071
[TBL] [Abstract][Full Text] [Related]
15. Urocortin protects cardiac myocytes from ischemia/reperfusion injury by attenuating calcium-insensitive phospholipase A2 gene expression.
Lawrence KM; Scarabelli TM; Turtle L; Chanalaris A; Townsend PA; Carroll CJ; Hubank M; Stephanou A; Knight RA; Latchman DS
FASEB J; 2003 Dec; 17(15):2313-5. PubMed ID: 14563694
[TBL] [Abstract][Full Text] [Related]
16. Magnesium antagonizes the actions of lysophosphatidyl choline (LPC) in myocardial cells: a possible mechanism for its antiarrhythmic effects.
Prielipp RC; Butterworth JF; Roberts PR; Black KW; Zaloga GP
Anesth Analg; 1995 Jun; 80(6):1083-7. PubMed ID: 7762833
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y
Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313
[TBL] [Abstract][Full Text] [Related]
18. Role of phospholipases A2 and C in myocardial ischemic reperfusion injury.
Prasad MR; Popescu LM; Moraru II; Liu XK; Maity S; Engelman RM; Das DK
Am J Physiol; 1991 Mar; 260(3 Pt 2):H877-83. PubMed ID: 2000982
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidylcholine, a metabolite which accumulates early in myocardium during ischemia, reduces gap junctional coupling in cardiac cells.
Daleau P
J Mol Cell Cardiol; 1999 Jul; 31(7):1391-401. PubMed ID: 10403756
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidylcholine induces Ca2+-independent cellular injury attenuated by d-propranolol in rat cardiomyocytes.
Chen M; Hashizume H; Xiao CY; Hara A; Abiko Y
Life Sci; 1997; 60(3):PL57-62. PubMed ID: 9000651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
